NASDAQ:THOR - Thoratec Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Thoratec Corporation develops, manufactures and markets medical devices used for mechanical circulatory support for the treatment of heart failure patients. The Company's products include ventricular assist devices (VADs), such as HeartMate II Left Ventricular Assist System (HeartMate II), HeartMate III Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device (PVAD) and Thoratec Implantable Ventricular Assist Device (IVAD). For acute circulatory support, the Company's product lines are CentriMag Acute Circulatory System (CentriMag) and for pediatric patients PediMag/PediVAS Acute Circulatory System (PediMag/PediVAS). HeartMate III, a centrifugal-flow, chronic, left ventricular assist system.

Receive THOR News and Ratings via Email

Sign-up to receive the latest news and ratings for THOR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
SymbolNASDAQ:THOR
CUSIP88517530
Phone+1-925-8478600

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins10.29%
Return on Equity8.02%
Return on Assets6.71%

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00

Thoratec (NASDAQ:THOR) Frequently Asked Questions

What is Thoratec's stock symbol?

Thoratec trades on the NASDAQ under the ticker symbol "THOR."

How were Thoratec's earnings last quarter?

Thoratec Co. (NASDAQ:THOR) released its earnings results on Tuesday, August, 4th. The medical instruments supplier reported $0.37 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.28 by $0.09. The medical instruments supplier had revenue of $128.70 million for the quarter, compared to the consensus estimate of $115.48 million. Thoratec had a net margin of 10.29% and a return on equity of 8.02%. The company's revenue was up 9.0% compared to the same quarter last year. During the same period in the prior year, the company posted $0.43 EPS. View Thoratec's Earnings History.

How do I buy shares of Thoratec?

Shares of THOR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Thoratec's official website?

The official website for Thoratec is http://www.thoratec.com/.

How can I contact Thoratec?

Thoratec's mailing address is 6035 Stoneridge Dr, PLEASANTON, CA 94588, United States. The medical instruments supplier can be reached via phone at +1-925-8478600.


MarketBeat Community Rating for Thoratec (NASDAQ THOR)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  320 (Vote Outperform)
Underperform Votes:  337 (Vote Underperform)
Total Votes:  657
MarketBeat's community ratings are surveys of what our community members think about Thoratec and other stocks. Vote "Outperform" if you believe THOR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe THOR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel